00567nas a2200157   4500000000100000008004100001100001400042700001700056700005200073700001400125700001600139245021800155300002300373490000700396050000600403       2006                            d1 aLipman J.1 aFinfer Simon1 aANZICS Clinical Trial Group (Writing Committee)1 aFelton T.1 aBlundell A.00aEstimate of the number of patients eligible for treatment with drotrecogin alfa (activated) based on differing international indications: post-hoc analysis of an inception cohort study in Australia and New Zealand  a184-90. [IF 0.896]0 v34  aY